New Evidence on Bioelectrical Impact on Biofilms

Vomaris Innovations Inc (Tempe, AZ) announced that its Advanced Microcurrent Technology was successful in disrupting biofilm in the first controlled, preclinical, in vivo porcine model study. Published in Annals of Surgery, the study found that the bioelectrical antimicrobial technology circumvented biofilm formation, disrupted infection and related pathological complications, and blunted the expression of quorum sensing genes in bacteria, effectively disabling the structural integrity of biofilm.

The company’s nonantibiotic antimicrobial technology is inspired by the body’s natural electrical healing process. It uses embedded microcell batteries to generate electrical fields similar to the body’s own physiologic electrical fields which are essential for cell migration and wound healing. The currently cleared product has broad indications in the prescription wound care market and is cleared for over-the-counter usage.

Click here for more information.